The end is just the beginning: Megakaryocyte apoptosis and platelet release

International Journal of Hematology

Volumn 74, Issue 4, 2001, Pages 365-374

  Li, Junzhi ^a   Kuter, David J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Megakaryocyte; Platelet production; Proplatelet; Thrombopoietin

Indexed keywords

THROMBOPOIETIN;

ANIMAL; APOPTOSIS; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; HEMATOPOIESIS; HUMAN; MEGAKARYOCYTE; METABOLISM; PHYSIOLOGY; REVIEW; THROMBOCYTE;

ANIMALS; APOPTOSIS; BLOOD PLATELETS; CELL DIFFERENTIATION; HEMATOPOIESIS; HUMANS; MEGAKARYOCYTES; THROMBOPOIETIN;

EID: 0035756684     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982078     Document Type: Article

References (22)

1. McDonald TP,Wendling F, Vainchenker W, McCarty JM, Jorgenson MJ, Kaushansky K. Thrombopoietin from human embryonic kidney cells is the same factor as c-mpl-ligand [letter]. Blood. 1995;85: 292-294.
2. McDonald TP, Cottrell MB, Swearingen CJ, Clift RE. Comparative effects of thrombopoietin and interleukin-6 on murine megakaryocytopoiesis and platelet production. Blood. 1991;77:735-740.
3. Ballmaier M, Germeshausen M, Schulze H, et al. C-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001;97:139-146.
4. Drachman JG, Rojnuckarin P, Kaushansky K. Thrombopoietin signal transduction: studies from cell lines and primary cells. Methods. 1999;17:238-249.
5. Kaushansky K. Thrombopoietin and hematopoietic stem cell development. Ann NY Acad Sci. 1999;872:314-319.
6. Broudy VC, Kaushansky K. Biology of thrombopoietin. Curr Opin Pediatr. 1998;10:60-64.
7. Kuter DJ. Thrombopoietin: biology and clinical applications. Oncologist. 1996;2:98-106.
8. Kuter DJ. Future directions with platelet growth factors. Semin Hematol. 2000;37:41-49.
9. Katsurada T, Adachi M, Kido H, et al. Induction of apoptosis in megakaryocytic leukemia cell lines by MX2, a morpholino anthracycline. Exp Hematol. 1997;25:1077-1083.
10. 3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages. Lenk Lymphoma. 2000;38:153-163.
11. Battinelli E, Loscalzo J. Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood. 2000;95:3451-3459.
12. Osada M, Komeno T, Todokoro K, et al. Immature megakaryocytes undergo apoptosis in the absence of thrombopoietin. Exp Hematol. 1999;27:131-138.
13. Li J, Coburn J, Blatman RN, Kuter DJ. C-mpl-mediated inhibition of cord blood CD34-derived megakaryocyte apoptosis is associated with a reduction of platelet formation. J Thromb Haemost. 2001;86:P1863.
14. Zucker-Franklin D, Termin CS, Cooper MC. Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-1). Am J Pathol. 1989;134:1295-1303.
15. Zauli G, Catani L, Gibellini D, et al. Impaired survival of bone marrow GPIIb/IIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. Br J Haematol. 1996;92:711-717.
16. Harker LA, Marzec UM, Novembre F, et al. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor. Blood. 1998;91:4427-4433.
17. Hofmann WK, Kalina U, Koschmieder S, Seipelt G, Hoelzer D, Ottmann OG. Defective megakaryocytic development in myelodysplastic syndromes. Lenk Lymphoma. 2000;38:13-19.
18. Hatfill SJ, Fester ED, Steytler JG. Apoptotic megakaryocyte dysplasia in the myelodysplastic syndromes. Hematol Pathol. 1992;6: 87-93.
19. Bouscary D, Chen YL, Guesnu M, et al. Activity of the caspase-3/ CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro. Exp Hematol. 2000;28:784-791.
20. Ali A, Mundle SD, Ragasa D, et al. Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes. J Hematother Stem Cell Res. 1999;8:343-356.
21. Akahori H, Ozai M, Ida M, Shibuya K, Kalo T, Miyazaki H. Further examination of various administration protocols of pegylated recombinant human megakaryocyte growth and development fac tor on thrombocytopenia in myelosuppressed mice. Ther Apher. 1998;2:58-64.
22. Berger G, Hartwell DW, Wagner DD. P-selectin and platelet clearance. Blood. 1998;92:4446-4452.